Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Linker Drug Conjugate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116897149A details a scalable ADC linker synthesis. Achieve 98% purity with reduced steps. Reliable supply chain partner for pharmaceutical intermediates.
Patent CN116217654A reveals a stable intermediate route for LE14 ADC payloads, offering cost reduction in ADC manufacturing and reliable supply chain solutions.